{{Rsnum
|rsid=938682
|Gene=CHRNA3
|Chromosome=15
|position=78604205
|Orientation=minus
|GMAF=0.3535
|Gene_s=CHRNA3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.4 | 32.7 | 62.8
| HCB | 19.0 | 56.2 | 24.8
| JPT | 23.0 | 54.0 | 23.0
| YRI | 10.9 | 40.8 | 48.3
| ASW | 14.0 | 38.6 | 47.4
| CHB | 19.0 | 56.2 | 24.8
| CHD | 18.5 | 54.6 | 26.9
| GIH | 25.7 | 45.5 | 28.7
| LWK | 8.2 | 51.8 | 40.0
| MEX | 31.0 | 46.6 | 22.4
| MKK | 8.5 | 45.1 | 46.4
| TSI | 5.9 | 35.3 | 58.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23397474
|Title=Polymorphisms of CHRNA5-CHRNA3-CHRNB4 Gene Cluster and NSCLC Risk in Chinese Population
|OA=1
}}

{{PMID Auto
|PMID=18165968
|Title=Identification of pharmacogenetic markers in smoking cessation therapy.
|OA=1
}}

{{PMID Auto
|PMID=18519524
|Title=Variants in nicotinic receptors and risk for nicotine dependence.
|OA=1
}}

{{PMID Auto
|PMID=19443489
|Title=Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5.
|OA=1
}}

{{PMID Auto
|PMID=19654303
|Title=Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.
|OA=1
}}

{{PMID Auto
|PMID=19706762
|Title=The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans.
|OA=1
}}

{{PMID Auto
|PMID=22914670
|Title=Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}